Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Diuretic-Induced Potassium Depletion and Glucose Intolerance Are Not Related to Hyperactivity of the Renin-Angiotensin-Aldosterone System in Hypertensive Patients With the Metabolic Syndrome
The Journal of Clinical Hypertension, 09/15/09
Barbieri DE et al. – With therapy, PRA increased similarly in both groups while PA increased only in the MSG. However, greater reduction in plasma K occurred in the CG, and the 2 groups reached similar final K values. Impairment in glucose tolerance occurred in both groups, with no change in HOMA–beta in the CG and reduction in the MSG, suggesting that diuretic therapy increases insulin resistance and impairs insulin secretion independent of abdominal obesity. These alterations could not be attributed to hyperactivity of RAAS.
Douglas E. Barbieri, 09/15/09
| In contrast to other studies, our results did not show evidence of hyperactivity of RAAS in patients with abdominal obesity and metabolic syndrome. In a previous study, our group also observed that plasma potassium levels in abdominal obese patients, even without diuretic therapy, were lower than in nonobese hypertensive patients. This was attributed to a potential hyperactivity of the RAAS, not confirmed in the present study. Thus, the reasons for the lower levels of plasma K in our abdominal obese patients are not clear. The significant negative correlation found between baseline plasma insulin and plasma K in the present study could also suggest a role of hyperinsulinemia in the reduction of plasma potassium levels in abdominal obesity. Although more pronounced in obese patients, the disturbances in glucose metabolism induced by thiazide diuretic therapy seem independent of the presence of MS and can be attributed to worsening in both insulin resistance and secretion. |
Related Articles
Urocortin 2 Inhibits Furosemide-induced Activation of Renin and Enhances Renal Function and Diuretic Responsiveness in Experimental Heart Failure
Circulation: Heart Failure, 10/02/09
Relevance Score: 64%
Oral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09
Relevance Score: 45%
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Cancer Chemotherapy and Pharmacology, 10/05/09
Relevance Score: 45%
Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight
The Journal of Urology, 10/22/09
Relevance Score: 43%
Human Immunodeficiency Virus Type 1 Envelope gp120-Induced Partial T-Cell Receptor Signaling Creates an F-Actin-Depleted Zone in the Virological Synapse
Journal of Virology, 10/12/09
Relevance Score: 43%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis
Clinical Reviews in Allergy and Immunology, 12/18/09
Improved 24-Hour Blood Pressure Control With Sirolimus Versus Calcineurin Inhibitor Based Immunosuppression in Renal Transplant Recipients
Transplantation Proceedings, 12/18/09
Hypertensive encephalopathy in patients with chronic renal failure caused by stopping antihypertensive agents: a report of two cases
Clinical and Experimental Nephrology, 12/18/09
Article Search
Sponsor


See Latest Articles


